Indivior PLC
INDV21.180USD
+0.130+0.62%
交易中 （美东）报价延迟15分钟
2.65B总市值
亏损市盈率 TTM
关于 Indivior PLC 公司
Indivior PLC 是一家制药公司。该公司致力于开发治疗物质使用障碍 (SUD)、严重精神疾病和阿片类药物过量的药物。该公司拥有一系列候选产品，旨在治疗其他慢性病和 SUD 的并发疾病，包括酒精使用障碍和大麻使用障碍，以及包括精神分裂症在内的合并症。其核心产品包括 SUBLOCADE（丁丙诺啡缓释）月度注射剂；SUBOXONE 薄膜（丁丙诺啡和纳洛酮舌下薄膜）；SUBOXONE 片剂（丁丙诺啡和纳洛酮舌下片）和 SUBUTEX 片剂（丁丙诺啡舌下片）。该公司用于治疗阿片类药物障碍 (OUD) 的产品包括用于逆转阿片类药物过量用药的 OPVEE（纳美芬）鼻喷雾剂和用于治疗美国成人精神分裂症的 PERSERIS（利培酮）缓释注射混悬液。该公司的产品组合销往 37 个国家。
公司简介
公司代码INDV
公司名称Indivior PLC
上市日期Dec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
员工数量1030
证券类型Ordinary Share
年结日Dec 24
公司地址234 Bath Road
城市SLOUGH
上市交易所NASDAQ Global Select Consolidated
国家United Kingdom
邮编SL1 4EE
电话448043791090
网址https://www.indivior.com/en
公司代码INDV
上市日期Dec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
9.63K
+150.00%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
3.88K
+63.05%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
760.00
--
Mr. Stuart (Tony) Kingsley
Mr. Stuart (Tony) Kingsley
Independent Non-Executive Director
Independent Non-Executive Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
222.00M
83.46%
Rest of World
44.00M
16.54%
业务
地区
暂无数据
股东统计
更新时间: 7月2日 周三
更新时间: 7月2日 周三
持股股东
股东类型
持股股东
持股股东
占比
Two Seas Capital LP
9.35%
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.47%
BlackRock Investment Management (UK) Ltd.
6.63%
Goldman Sachs International
6.58%
Other
60.15%
持股股东
持股股东
占比
Two Seas Capital LP
9.35%
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.47%
BlackRock Investment Management (UK) Ltd.
6.63%
Goldman Sachs International
6.58%
Other
60.15%
股东类型
持股股东
占比
Hedge Fund
39.97%
Investment Advisor/Hedge Fund
20.90%
Investment Advisor
14.44%
Research Firm
10.94%
Individual Investor
3.88%
Pension Fund
0.36%
Family Office
0.21%
Bank and Trust
0.20%
Venture Capital
0.04%
Other
9.06%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
349
120.01M
95.70%
+8.27M
2025Q1
380
119.99M
96.15%
-1.70M
2024Q4
382
116.83M
93.64%
-10.43M
2024Q3
369
117.73M
91.72%
-15.91M
2024Q2
352
119.29M
90.10%
-8.99M
2024Q1
341
129.79M
96.57%
+3.79M
2023Q4
322
124.43M
92.28%
+2.93M
2023Q3
321
114.40M
84.40%
+17.06M
2023Q2
296
115.50M
83.90%
+12.51M
2023Q1
259
96.50M
70.33%
+1.18M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Two Seas Capital LP
12.07M
9.68%
+191.47K
+1.61%
Jun 17, 2025
Oaktree Capital Management, L.P.
11.01M
8.82%
+293.23K
+2.74%
Mar 31, 2025
Deerfield Management Company, L.P.
10.57M
8.47%
+4.00M
+60.90%
Mar 31, 2025
BlackRock Investment Management (UK) Ltd.
8.27M
6.63%
+8.27M
--
Jun 27, 2025
Goldman Sachs International
8.21M
6.58%
+1.28M
+18.51%
Mar 31, 2025
Madison Avenue Partners LP
7.79M
6.25%
+2.76M
+54.85%
Mar 31, 2025
Rubric Capital Management LP
4.70M
3.77%
+1.17M
+33.20%
Apr 21, 2025
The Vanguard Group, Inc.
4.61M
3.69%
+71.54K
+1.58%
Mar 31, 2025
UBS Financial Services, Inc.
3.53M
2.83%
+2.69M
+323.54%
Mar 31, 2025
Sirovich (Matthew I.)
3.42M
2.74%
+249.62K
+7.87%
Sep 30, 2024
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares MSCI United Kingdom Small-Cap ETF
0.34%
ProShares Ultra Nasdaq Biotechnology
0.21%
Invesco Nasdaq Biotechnology ETF
0.21%
Franklin US Small Cap Multifactor Index ETF
0.17%
Vanguard US Multifactor ETF
0.16%
Invesco International BuyBack Achievers ETF
0.13%
iShares Intl Small Cap Equity Factor ETF
0.11%
SPDR S&P International Small Cap ETF
0.11%
iShares MSCI Europe Small-Cap ETF
0.1%
iShares Russell 2000 Growth ETF
0.09%
查看更多
iShares MSCI United Kingdom Small-Cap ETF
占比0.34%
ProShares Ultra Nasdaq Biotechnology
占比0.21%
Invesco Nasdaq Biotechnology ETF
占比0.21%
Franklin US Small Cap Multifactor Index ETF
占比0.17%
Vanguard US Multifactor ETF
占比0.16%
Invesco International BuyBack Achievers ETF
占比0.13%
iShares Intl Small Cap Equity Factor ETF
占比0.11%
SPDR S&P International Small Cap ETF
占比0.11%
iShares MSCI Europe Small-Cap ETF
占比0.1%
iShares Russell 2000 Growth ETF
占比0.09%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
